We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Point of Care Testing (POCT) Market to Reach USD 46.7 Billion by 2024

By HospiMedica International staff writers
Posted on 22 Jan 2020
Print article
Illustration
Illustration
The global point of care testing (POCT) market is expected to surpass USD 37 billion by 2025, driven mainly by the migration of POCT from the hospital environment to a range of medical environments, including the workplace, home, disaster care and most recently, convenience clinics. POCT now appears to be headed for a bigger role in diagnosis and monitoring patient care. Additionally, growing awareness about early disease diagnosis and prevention has stimulated the demand for POCT for detecting cancer and infectious disease in the early stages. Moreover, the rising incidence of infectious diseases and chronic conditions, such as cardiovascular diseases and diabetes in the developing countries such as India and China, is stimulating the demand for POCT services.

These are the latest findings of iGATE Research (Delhi, India), a global specialist in the field of market research, analytics and consulting services.

Based on diagnostics, the POCT market is dominated by the Blood Glucose Testing segment, driven by the increasing prevalence of diabetes in the developing as well as developed economies and rising inclination among patients for home testing. However, the Cardiac Marker segment is projected to register the highest growth during the forecast period, led by the growing prevalence of cardiovascular ailments, increasing purchasing power, rising geriatric population associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in the rural areas.

On the basis of mode, the POCT market is dominated by the OTC-based Testing segment. OTC tests do not require a dedicated space unlike clinical laboratory tests and also have a quick turnaround time. However, the Prescription-based Testing segment is projected to register the highest growth during the forecast period.

Based on end-user, the POCT market is dominated by the Hospitals segment followed by the Clinics segment, driven by a higher prevalence of chronic conditions, such as cancer and cardiovascular diseases that require proper monitoring and minimally invasive procedures which are carried out in hospitals and clinics. However, the Home Care segment is projected to register the highest growth during the forecast period, led by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

Geographically, North America dominated the global POCT market in 2018 and is expected to maintain its leading position during the forecast period due to the rising prevalence of chronic disorders and infectious diseases, which require portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives for supporting the adoption of POCT in the region. Europe held the second-largest share of the global POCT market in 2018. However, the Asia-Pacific POCT market is projected to register the highest growth during the forecast period, driven by its growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies in the region.

Related Links:
iGATE Research

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Compact C-Arm
Arcovis DRF-C S21

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more